- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Oxford Nanopore sets IPO plans in motion
Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.
Sep 21, 2021Daily Deal Round Up: September 20, 2021
Ideo contributed to female-focused debit card provider Sequin's $5m seed round while Nikon has exited motion data software developer Wrnch.
Sep 20, 2021Daily deal net: September 20, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 20, 2021Caresyntax tracks up series C to $130m
ProAssurances and Reylens Group helped the surgical software provider add $30m to a series C round now totalling $130m.
Sep 20, 2021DeltaHealth raises pulse to $100m
Swire Pacific led a funding round for the cardiovascular healthcare provider as it prepares to expand its network of facilities in China.
Sep 20, 2021Wrnch pulls off acquisition
Hinge Health has bought Wrnch, a computer vision technology developer exploiting research from Concordia University.
Sep 20, 2021Anjarium apprehends $60m in series A funding
Pfizer Ventures participated in a series A round for genetic therapeutics developer Anjarium Biosciences that was co-led by Abingworth and Gimv.
Sep 20, 2021Analysis: Prenetics in a $1.25bn reverse merger
Alibaba and Ping An-backed Prenetics is set to complete a reverse merger at a $1.25bn valuation. Exits from the broader genetics and gene therapeutics space appear to be in the middle of a valuation spike, according to our data.
Sep 20, 2021Daily Deal Round Up: September 17, 2021
Conductive Ventures returned for online savings platform developer Self Financial's $50m series E round while EV producer Volta Trucks completed its $43.6m series B.
Sep 17, 2021Spring Health secures $190m
Digital mental health platform Spring Health was valued at $2bn through a series C round backed by strategic investor Guardian Life.
Sep 17, 2021Amolyt shows ambition with $80m series B
The endocrine disease treatment developer pushed its overall funding past $160m in a round featuring Novo, Sham and Mass General Brigham.
Sep 17, 2021Prenetics tests out $1.25bn reverse merger
Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.
Sep 17, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


